SARS-CoV-2 Vaccine Acceptability in Patients on Hemodialysis: A Nationwide Survey

Author:

Garcia Pablo,Montez-Rath Maria E.ORCID,Moore Heather,Flotte Johnie,Fults Chris,Block Martha S.,Han JialinORCID,Dittrich Mary,Parsonnet JulieORCID,Chertow Glenn M.,Block Geoffrey A.,Anand ShuchiORCID

Abstract

BackgroundPatients on dialysis are at increased risk for COVID-19–related complications. However, a substantial fraction of patients on dialysis belong to groups more likely to be hesitant about vaccination.MethodsWith the goal of identifying strategies to increase COVID-19 vaccine uptake among patients on hemodialysis, we conducted a nationwide vaccine acceptability survey, partnering with a dialysis network to distribute an anonymized English and Spanish language online survey in 150 randomly selected facilities in the United States. We used logistic regression to evaluate characteristics of vaccine-hesitant persons.ResultsA total of 1515 (14% of eligible) patients responded; 20% of all responders, 29% of patients aged 18–44 years, and 29% of Black responders reported being hesitant to seek the COVID-19 vaccine, even if the vaccine was considered safe for the general population. Odds of vaccine hesitancy were higher among patients aged 18–44 years versus those 45–64 years (odds ratio [OR], 1.5; 95% confidence interval [95% CI], 1.0 to 2.3), Black patients versus non-Hispanic White patients (OR, 1.9; 95% CI, 1.3 to 2.7), Native Americans or Pacific Islanders versus non-Hispanic White patients (OR, 2.0; 95% CI, 1.1 to 3.7), and women versus men (OR, 1.6; 95% CI, 1.2 to 2.0). About half (53%) of patients who were vaccine hesitant expressed concerns about side effects. Responders’ main information sources about COVID-19 vaccines were television news and dialysis staff (68% and 38%, respectively).ConclusionsA substantial proportion of patients receiving in-center hemodialysis in the United States are hesitant about seeking COVID-19 vaccination. Facilitating uptake requires outreach to younger patients, women, and Black, Native American, or Pacific Islander patients, and addressing concerns about side effects.PodcastThis article contains a podcast at https://www.asn-online.org/media/podcast/JASN/2021_07_07_JASN2021010104.mp3

Funder

American Kidney Fund

Stanford University School of Medicine

NIDDK

Publisher

American Society of Nephrology (ASN)

Subject

Nephrology,General Medicine

Reference18 articles.

1. Centers for Medicare and Medicaid Services : Preliminary Medicare COVID-19 data snapshot. 2021. Available at: https://www.cms.gov/research-statistics-data-systems/preliminary-medicare-covid-19-data-snapshot. Accessed February 20, 2021

2. Outcomes of patients with end-stage kidney disease hospitalized with COVID-19;Ng;Kidney Int,2020

3. COVID-19 infection risk among hemodialysis patients in long-term care facilities;Liu;Kidney Med,2020

4. Attitudes Toward a Potential SARS-CoV-2 Vaccine

5. Funk C , Tyson A : Intent to get a COVID-19 vaccine rises to 60% as confidence in research and development process increases, 2020. Available at: https://www.pewresearch.org/science/2020/12/03/intent-to-get-a-covid-19-vaccine-rises-to-60-as-confidence-in-research-and-development-process-increases/. Accessed January 21, 2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3